Piper Sandler raised the firm’s price target on Labcorp (LH) to $260 from $240 following quarterly results. The firm keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp’s Earnings Call Highlights Growth and Optimism
- Labcorp price target raised to $248 from $231 at Deutsche Bank
- Robust Financial Performance and Positive Outlook Support Buy Rating for Labcorp Holdings
- Labcorp price target raised to $293 from $291 at Baird
- Labcorp price target raised to $282 from $271 at BofA